MeCP2 controls the expression of RASAL1 in the hepatic fibrosis in rats

Toxicology

Volumn 290, Issue 2-3, 2011, Pages 327-333

  Tao, Hui ^a   Huang, Cheng ^a   Yang, Jing Jing ^a   Ma, Tao Tao ^a   Bian, Er Bao ^a   Zhang, Lei ^a   Lv, Xiong Wen ^a   Jin, Yong ^a   Li, Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

DNA methylation; Extracellular signal regulated kinase signaling; Hepatic stellate cells; Liver fibrosis; Methyl CpG binding protein 2; Ras GTPase activating like protein 1

Indexed keywords

MESSENGER RNA; METHYL CPG BINDING PROTEIN 2; PROTEIN; RAS GTPASE ACTIVATING LIKE PROTEIN 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DNA METHYLATION; FIBROBLAST; FIBROGENESIS; GENE SILENCING; LIVER FIBROSIS; MALE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

RATTUS;

EID: 84858624156     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2011.10.011     Document Type: Article

References (43)

1. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 1999, 23:185-188.
2. Apte M.V., Wilson J.S. Mechanisms of pancreatic fibrosis. Dig. Dis. 2004, 22:273-279.
3. Bataller R., Brenner D.A. Liver fibrosis. J. Clin. Invest. 2005, 115:209-218.
4. Bechtel W., McGoohan S., Zeisberg E.M., Muller G.A., Kalbacher H., Salant D.J., Muller C.A., Kalluri R., Zeisberg M. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat. Med. 2010, 16:544-550.
5. Benyon R.C., Arthur M.J. Extracellular matrix degradation and the role of hepatic stellate cells. Semin. Liver Dis. 2001, 21:373-384.
6. Burke Z.D., Tosh D. Therapeutic potential of transdifferentiated cells. Clin. Sci. (Lond) 2005, 108:309-321.
7. Calvisi D.F., Ladu S., Conner E.A., Seo D., Hsieh J.T., Factor V.M., Thorgeirsson S.S. Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer. J. Hepatol. 2010, 54:311-319.
8. Desmouliere A., Chaponnier C., Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen. 2005, 13:7-12.
9. Desmouliere A., Guyot C., Gabbiani G. The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int. J. Dev. Biol. 2004, 48:509-517.
10. Ding M., Cui S., Li C., Jothy S., Haase V., Steer B.M., Marsden P.A., Pippin J., Shankland S., Rastaldi M.P., Cohen C.D., Kretzler M., Quaggin S.E. Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice. Nat. Med. 2006, 12:1081-1087.
11. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 2003, 3:11-22.
12. Foo N.P., Lin S.H., Lee Y.H., Wu M.J., Wang Y.J. Alpha-Lipoic acid inhibits liver fibrosis through the attenuation of ROS-triggered signaling in hepatic stellate cells activated by PDGF and TGF-beta. Toxicology 2011, 282:39-46.
13. Fujita N., Takebayashi S., Okumura K., Kudo S., Chiba T., Saya H., Nakao M. Methylation-mediated transcriptional silencing in euchromatin by methyl-CpG binding protein MBD1 isoforms. Mol. Cell. Biol. 1999, 19:6415-6426.
14. Ghoshal K., Datta J., Majumder S., Bai S., Kutay H., Motiwala T., Jacob S.T. 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal. Mol. Cell. Biol. 2005, 25:4727-4741.
15. Han Y., Amin H.M., Frantz C., Franko B., Lee J., Lin Q., Lai R. Restoration of shp1 expression by 5-AZA-2'-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma. Leukemia 2006, 20:1602-1609.
16. Im H.I., Hollander J.A., Bali P., Kenny P.J. MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat. Neurosci. 2010, 13:1120-1127.
17. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 2003, 24:5-254.
18. +)-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:12353-12358.
19. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat. Rev. Cancer 2006, 6:392-401.
20. Kolfschoten I.G., van Leeuwen B., Berns K., Mullenders J., Beijersbergen R.L., Bernards R., Voorhoeve P.M., Agami R. A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell 2005, 121:849-858.
21. Kristensen D.B., Kawada N., Imamura K., Miyamoto Y., Tateno C., Seki S., Kuroki T., Yoshizato K. Proteome analysis of rat hepatic stellate cells. Hepatology 2000, 32:268-277.
22. Lafyatis R. Targeting fibrosis in systemic sclerosis. Endocr. Metab. Immune Disord. Drug Targets 2006, 6:395-400.
23. Mann D.A., Smart D.E. Transcriptional regulation of hepatic stellate cell activation. Gut 2002, 50:891-896.
24. Mann J., Chu D.C., Maxwell A., Oakley F., Zhu N.L., Tsukamoto H., Mann D.A. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology 2010, 138. e701-704.
25. Mann J., Oakley F., Akiboye F., Elsharkawy A., Thorne A.W., Mann D.A. Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis. Cell Death Differ. 2007, 14:275-285.
26. Margueron R., Trojer P., Reinberg D. The key to development: interpreting the histone code?. Curr. Opin. Genet. Dev. 2005, 15:163-176.
27. Mitin N., Rossman K.L., Der C.J. Signaling interplay in Ras superfamily function. Curr. Biol. 2005, 15:R563-R574.
28. Nan X., Campoy F.J., Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 1997, 88:471-481.
29. Nishioka C., Ikezoe T., Yang J., Komatsu N., Koeffler H.P., Yokoyama A. Blockade of MEK signaling potentiates 5-Aza-2'-deoxycytidine-induced apoptosis and upregulation of p21(waf1) in acute myelogenous leukemia cells. Int. J. Cancer 2009, 125:1168-1176.
30. Oakley F., Meso M., Iredale J.P., Green K., Marek C.J., Zhou X., May M.J., Millward-Sadler H., Wright M.C., Mann D.A. Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology 2005, 128:108-120.
31. Ogawa S., Ochi T., Shimada H., Inagaki K., Fujita I., Nii A., Moffat M.A., Katragadda M., Violand B.N., Arch R.H., Masferrer J.L. Anti-PDGF-B monoclonal antibody reduces liver fibrosis development. Hepatol. Res. 2010, 40:1128-1141.
32. Ohyama T., Yamazaki Y., Sato K., Horiguchi N., Ichikawa T., Kakizaki S., Takagi H., Mori M. Transforming growth factor-alpha attenuates hepatic fibrosis: possible involvement of matrix metalloproteinase-1. Liver Int. 2011, 31:572-584.
33. Olsen A.L., Bloomer S.A., Chan E.P., Gaca M.D., Georges P.C., Sackey B., Uemura M., Janmey P.A., Wells R.G. Hepatic stellate cells require a stiff environment for myofibroblastic differentiation. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301:G110-G118.
34. Ramani K., Yang H., Kuhlenkamp J., Tomasi L., Tsukamoto H., Mato J.M., Lu S.C. Changes in the expression of methionine adenosyltransferase genes and S-adenosylmethionine homeostasis during hepatic stellate cell activation. Hepatology 2010, 51:986-995.
35. Robert M.F., Morin S., Beaulieu N., Gauthier F., Chute I.C., Barsalou A., MacLeod A.R. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat. Genet. 2003, 33:61-65.
36. Sancho-Bru P., Bataller R., Gasull X., Colmenero J., Khurdayan V., Gual A., Nicolas J.M., Arroyo V., Gines P. Genomic and functional characterization of stellate cells isolated from human cirrhotic livers. J. Hepatol. 2005, 43:272-282.
37. Strutz F., Muller G.A. Renal fibrosis and the origin of the renal fibroblast. Nephrol. Dial. Transplant. 2006, 21:3368-3370.
38. Thannickal V.J., Toews G.B., White E.S., Lynch J.P., Martinez F.J. Mechanisms of pulmonary fibrosis. Annu Rev Med 2004, 55:395-417.
39. Tudor M., Akbarian S., Chen R.Z., Jaenisch R. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:15536-15541.
40. + oscillations. EMBO J. 2004, 23:1749-1760.
41. Wang Z., Xu J.P., Zheng Y.C., Chen W., Sun Y.W., Wu Z.Y., Luo M. Peroxisome proliferator-activated receptor gamma inhibits hepatic fibrosis in rats. Hepatobiliary Pancreat. Dis. Int. 2011, 10:64-71.
42. Weber K.T., Brilla C.G. Factors associated with reactive and reparative fibrosis of the myocardium. Basic Res. Cardiol. 1992, 87(Suppl. 1):291-301.
43. Wheeler M.T., McNally E.M. The interaction of coronary tone and cardiac fibrosis. Curr. Atheroscler. Rep. 2005, 7:219-226.